Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis

Overview of attention for article published in Advances in Therapy, February 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,851 followers.

RT @AdvancesTherapy: Subgroup analysis investigates Chinese patients included in the INPULSIS® trials on #nintedanib in idiopathic pulmonar…

RT @AdvancesTherapy: Subgroup analysis investigates Chinese patients included in the INPULSIS® trials on #nintedanib in idiopathic pulmonar…

Subgroup analysis investigates Chinese patients included in the INPULSIS® trials on #nintedanib in idiopathic pulmonary fibrosis: https://t.co/8jS4vkoGUq #IPF https://t.co/HmO40uH41o